{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T10:59:06Z","timestamp":1771671546231,"version":"3.50.1"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T00:00:00Z","timestamp":1683504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Primary HPT (PHPT) is a common disorder, affecting approximately 1% of the general population. Parathyroid adenomas emerge as non-familial sporadic in 90% of cases. The aim of this review is to give a detailed update of molecular genetics of sporadic parathyroid adenoma reported in international literature.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A bibliographic research was conducted in PubMed, Google Scholar, and Scopus.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Seventy-eight articles were included in our review. CaSR, MEN1, CCND1\/PRAD, CDKI, angiogenic factors like VEGF, FGF, TGF\u03b2, and IGF1, and apoptotic factors are important genes in parathyroid adenomas pathogenesis that have been established by several studies. A huge list of proteins is differently expressed in parathyroid adenomas measured by Western Blotting, MALDI\/TOF, MS spectrometry, and immunohistochemistry. These proteins take part in several cell processes such as cell metabolism, cytoskeleton structural stability, cell oxidative stress regulation, cell death, transcription, translation, cell connection, and cell signaling transmission, while they can be found over- or underexpressed in abnormal tissues.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This review gives a detailed analysis of all reported data on genomics and proteomics of parathyroid adenoma. Further studies should be applied on understanding parathyroid adenoma pathogenesis and introducing new biomarkers for early detection of primary hyperparathyroidism.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2023.1180211","type":"journal-article","created":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T04:58:22Z","timestamp":1683521902000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Sporadic parathyroid adenoma: an updated review of molecular genetics"],"prefix":"10.3389","volume":"14","author":[{"given":"Angeliki","family":"Chorti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angeliki","family":"Cheva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthoula","family":"Chatzikyriakidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charoula","family":"Achilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kassiani","family":"Boulogeorgou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krokou","family":"Despoina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanos","family":"Milias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Zarampoukas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodossis","family":"Papavramidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4677","article-title":"Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the fifth international workshop","volume":"37","author":"Bilezikian","year":"2022","journal-title":"J Bone Mineral Res"},{"key":"B2","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s12022-022-09709-1","article-title":"Overview of the 2022 WHO classification of parathyroid tumors","volume":"33","author":"Erickson","year":"2022","journal-title":"Endocrine Pathol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10391","article-title":"Normocalcemic hyperparathyroidism: a heterogeneous disorder often misdiagnosed","volume":"4","author":"Zavatta","year":"2020","journal-title":"JBMR plus"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.20945\/2359-3997000000556","article-title":"Cetani f normocalcemic primary hyperparathyroidism","volume":"66","author":"Cusano","year":"2022","journal-title":"Arch Endocrinol Metab"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1677\/ERC-09-0147","article-title":"Beta-catenin activation is not involved in sporadic parathyroid carcinomas and adenomas","volume":"17","author":"Cetani","year":"2010","journal-title":"Endocrine-related Cancer"},{"key":"B6","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/hed.23656","article-title":"Molecular profiling in primary hyperparathyroidism","volume":"37","author":"Segiet","year":"2014","journal-title":"Head Neck"},{"key":"B7","doi-asserted-by":"publisher","first-page":":11206","DOI":"10.3390\/ijms222011206","article-title":"Parathyroid tumors: molecular signatures","volume":"22","author":"Marini","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B8","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1159\/000345675","article-title":"Genetic defects associated with familial and sporadic hyperparathyroidism","author":"Hendy","year":"2013","journal-title":"Front hormone Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.2174\/156652413804810763","article-title":"D'Herde K the calcium-sensing receptor as a regulator of cellular fate in normal and pathological conditions","volume":"13","author":"Diez-Fraile","year":"2013","journal-title":"Curr Mol Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2015-203186","article-title":"Mete O clinicopathological correlates of hyperparathyroidism","volume":"68","author":"Duan","year":"2015","journal-title":"J Clin Pathol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-18-0304","article-title":"Molecular genetic insights into sporadic primary hyperparathyroidism","volume":"26","author":"Brewer","year":"2019","journal-title":"Endocrine-related Cancer"},{"key":"B12","article-title":"Major molecular genetic drivers in sporadic primary hyperparathyroidism","volume":"127","author":"Arnold","year":"2016","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"B13","doi-asserted-by":"publisher","first-page":"60","DOI":"10.11138\/ccmbm\/2017.14.1.060","article-title":"Molecular genetics in primary hyperparathyroidism: the role of genetic tests in differential diagnosis, disease prevention strategy, and therapeutic planning. a 2017 update","volume":"14","author":"Marini","year":"2017","journal-title":"Clin Cases Miner Bone Metab"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12458","article-title":"Molecular genetics and epigenetics of nonfamilial (sporadic) parathyroid tumours","volume":"280","author":"Westin","year":"2016","journal-title":"J Internal Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-1338","article-title":"Somatic mutation and germline sequence abnormalities in CDKN1B, encoding p27Kip1, in sporadic parathyroid adenomas","volume":"96","author":"Costa-Guda","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B16","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1038\/s41598-017-03143-8","article-title":"Promoter hypermethylation inactivates CDKN2A, CDKN2B and RASSF1A genes in sporadic parathyroid adenomas","volume":"7","author":"Arya","year":"2017","journal-title":"Sci Rep"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-019-01098-3","article-title":"Dysregulated mitogen-activated protein kinase pathway mediated cell cycle disruption in sporadic parathyroid tumors","volume":"43","author":"Arya","year":"2020","journal-title":"J Endocrinological Invest"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-2554","article-title":"Absence of stabilizing mutations of beta-catenin encoded by CTNNB1 exon 3 in a large series of sporadic parathyroid adenomas","volume":"92","author":"Costa-Guda","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040328","article-title":"An LRP5 receptor with internal deletion in hyperparathyroid tumors with implications for deregulated WNT\/beta-catenin signaling","volume":"4","author":"Bj\u00f6rklund","year":"2007","journal-title":"PloS Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-011-9558-y","article-title":"A rare S33C mutation of CTNNB1 encoding beta-catenin in a parathyroid adenoma found in an Italian primary hyperparathyroid cohort","volume":"41","author":"Guarnieri","year":"2012","journal-title":"Endocrine"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-012-9690-3","article-title":"Evidence of a stabilizing mutation of beta-catenin encoded by CTNNB1 exon 3 in a large series of sporadic parathyroid adenomas","volume":"42","author":"Starker","year":"2012","journal-title":"Endocrine"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.853171","article-title":"Germline mutations related to primary hyperparathyroidism identified by next-generation sequencing","volume":"13","author":"Park","year":"2022","journal-title":"Front Endocrinol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.18388\/abp.2009_2519","article-title":"The profile of ErbB\/Her family genes copy number assessed by real-time PCR in parathyroid adenoma and hyperplasia associated with sporadic primary hyperparathyroidism","volume":"56","author":"Bednarz","year":"2009","journal-title":"Acta Biochim Pol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.8.8707","article-title":"Mutational analysis of Smad3, a candidate tumor suppressor implicated in TGF-beta and menin pathways, in parathyroid adenomas and enteropancreatic endocrine tumors","volume":"87","author":"Shattuck","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.080903","article-title":"Analysis of CYP27B1, encoding 25-hydroxyvitamin d-1alpha-hydroxylase, as a candidate tumor suppressor gene in primary and severe secondary\/tertiary hyperparathyroidism","volume":"24","author":"Lauter","year":"2009","journal-title":"J Bone Mineral Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1460209","article-title":"Chromosomal imbalances identified by comparative genomic hybridization in sporadic parathyroid adenomas","volume":"146","author":"Garcia","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1210\/en.2018-00246","article-title":"Whole-exome sequencing identifies novel recurrent somatic mutations in sporadic parathyroid adenomas","volume":"159","author":"Wei","year":"2018","journal-title":"Endocrinology"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-2789","article-title":"Frequent large germline HRPT2 deletions in a French national cohort of patients with primary hyperparathyroidism","volume":"98","author":"Bricaire","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-02517","article-title":"Analysis of activating GCM2 sequence variants in sporadic parathyroid adenomas","volume":"104","author":"Riccardi","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1210\/jc.83.5.1766","article-title":"Novel chromosomal abnormalities identified by comparative genomic hybridization in parathyroid adenomas","volume":"83","author":"Palanisamy","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s12253-011-9483-7","article-title":"Molecular profiling of parathyroid hyperplasia, adenoma and carcinoma","volume":"18","author":"Arvai","year":"2012","journal-title":"Pathol Oncol Res POR"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-02506","article-title":"Identification of differential transcriptional patterns in primary and secondary hyperparathyroidism","volume":"103","author":"Sadowski","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1530\/EC-17-0283","article-title":"Diagnosis, management, histology and genetics of sporadic primary hyperparathyroidism: old knowledge with new tricks","volume":"7","author":"Mizamtsidi","year":"2018","journal-title":"Endocrine Connections"},{"key":"B34","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.mce.2017.10.001","article-title":"Molecular profiles of oxyphilic and chief cell parathyroid adenoma","volume":"470","author":"Lu","year":"2018","journal-title":"Mol Cell Endocrinol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2013.06.044","article-title":"Development of a calcium-sensing receptor molecular imaging agent","volume":"154","author":"Yusof","year":"2013","journal-title":"Surgery"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-018-0958-1","article-title":"Quantitative proteomics analysis of sporadic parathyroid adenoma tissue samples","volume":"42","author":"Arya","year":"2019","journal-title":"J Endocrinological Invest"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-13-0085","article-title":"Simultaneous expression analysis of vitamin d receptor, calcium-sensing receptor, cyclin D1, and PTH in symptomatic primary hyperparathyroidism in Asian indians","volume":"169","author":"Varshney","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1477-5956-9-29","article-title":"Evaluation of formalin-fixed paraffin-embedded tissues in the proteomic analysis of parathyroid glands","volume":"9","author":"Donadio","year":"2011","journal-title":"Proteome Sci"},{"key":"B39","doi-asserted-by":"publisher","first-page":"197","DOI":"10.21873\/cgp.20031","article-title":"Proteomics analysis of tissue samples reveals changes in mitochondrial protein levels in parathyroid hyperplasia over adenoma","volume":"14","author":"Akpinar","year":"2017","journal-title":"Cancer Genomics Proteomics"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1039\/C0MB00191K","article-title":"A proteomic approach to study parathyroid glands","volume":"7","author":"Giusti","year":"2011","journal-title":"Mol Biosyst"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0036448","article-title":"Prolactin receptor in primary hyperparathyroidism\u2013expression, functionality and clinical correlations","volume":"7","author":"Haglund","year":"2012","journal-title":"PloS One"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1180211\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T04:58:25Z","timestamp":1683521905000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1180211\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,8]]},"references-count":41,"alternative-id":["10.3389\/fendo.2023.1180211"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1180211","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,8]]},"article-number":"1180211"}}